Kellanova's Q3 Net Income Dips Amidst Merger Uncertainty

TL;DR

**Kellanova's declining net income and cash position make the proposed $83.50 merger a critical lifeline, but regulatory hurdles loom large.**

AI Summary

Kellanova reported a slight increase in net sales for the quarter ended September 27, 2025, reaching $3,260 million, up from $3,233 million in the prior year quarter. However, net income attributable to Kellanova decreased to $309 million, down from $367 million in the same quarter of 2024, representing a 15.8% decline. Diluted earnings per share also fell to $0.88 from $1.05. Year-to-date net sales decreased to $9,546 million from $9,625 million, while year-to-date net income attributable to Kellanova dropped to $912 million from $978 million. Operating profit for the quarter was $452 million, a slight decrease from $456 million in the prior year. Cash and cash equivalents significantly declined to $240 million as of September 27, 2025, from $694 million at December 28, 2024. The company is currently subject to a proposed merger with Acquiror 10VB8, LLC, at $83.50 per share, pending European Commission antitrust approval. The separation of its North America cereal business into WK Kellogg Co in Q4 2023 continues to impact operations, with transitional services under the TSA concluding and supply agreements still in effect.

Why It Matters

This filing reveals Kellanova's struggle to maintain profitability despite a slight sales uptick, which could concern investors looking for consistent growth, especially with a proposed merger on the table. The pending European Commission antitrust approval for the $83.50 per share merger with Acquiror 10VB8, LLC, introduces significant uncertainty, impacting share price and investor confidence. For employees, the merger's outcome could dictate future employment and organizational structure. Competitively, a successful merger could strengthen Kellanova's market position, while a failed one could leave it vulnerable, especially as it navigates the post-spin-off landscape with WK Kellogg Co.

Risk Assessment

Risk Level: high — The company faces high risk due to the pending merger with Acquiror 10VB8, LLC, which is subject to European Commission antitrust approval. If the merger fails due to regulatory issues, Acquiror would pay a $1.25 billion termination fee, but if Kellanova terminates for a superior proposal or due to a change of recommendation, it would owe Acquiror $800 million, creating significant financial exposure and uncertainty. Additionally, cash and cash equivalents plummeted from $694 million at December 28, 2024, to $240 million at September 27, 2025, indicating a substantial reduction in liquidity.

Analyst Insight

Investors should closely monitor the European Commission's decision on the proposed merger, as its outcome will significantly impact Kellanova's stock price. Given the decline in net income and cash, consider whether the $83.50 per share offer fully reflects the company's intrinsic value and future prospects, especially if the merger falls through.

Financial Highlights

debt To Equity

2.06

revenue

$3,260 million

operating Margin

13.9%

total Assets

$15,645 million

total Debt

$5,099 million

net Income

$309 million

eps

$0.88

gross Margin

32.4%

cash Position

$240 million

revenue Growth

0.8%

Key Numbers

• $3,260 million — Net sales for Q3 2025 (Slight increase from $3,233 million in Q3 2024)
• $309 million — Net income attributable to Kellanova for Q3 2025 (Decreased from $367 million in Q3 2024)
• $0.88 — Diluted earnings per share for Q3 2025 (Decreased from $1.05 in Q3 2024)
• $9,546 million — Year-to-date net sales for 2025 (Decreased from $9,625 million in 2024)
• $912 million — Year-to-date net income attributable to Kellanova for 2025 (Decreased from $978 million in 2024)
• $240 million — Cash and cash equivalents as of September 27, 2025 (Significant decrease from $694 million at December 28, 2024)
• $83.50 — Per share merger consideration (Cash price offered in the proposed merger with Acquiror 10VB8, LLC)
• $1.25 billion — Acquiror termination fee (Payable to Kellanova if merger fails due to regulatory approvals)
• $800 million — Kellanova termination fee (Payable to Acquiror under certain specified circumstances)
• 347,932,629 — Common Stock outstanding (Shares outstanding as of September 27, 2025)

Key Players & Entities

• Kellanova (company) — Registrant in 10-Q filing
• Acquiror 10VB8, LLC (company) — Proposed merger partner
• Merger Sub 10VB8, LLC (company) — Wholly owned subsidiary of Acquiror 10VB8, LLC
• Mars, Incorporated (company) — Party to the Merger Agreement for limited purposes
• European Commission (regulator) — Regulatory body for antitrust approval of merger
• WK Kellogg Co (company) — Company spun off from Kellanova's North America cereal business
• $83.50 (dollar_amount) — Per share cash consideration in proposed merger
• $1.25 billion (dollar_amount) — Termination fee payable by Acquiror if merger fails due to regulatory approvals
• $800 million (dollar_amount) — Termination fee payable by Kellanova under certain circumstances
• FASB (regulator) — Issued ASU 2023-09 and ASU 2024-03

FAQ

Risk Factors

• Merger Approval Uncertainty [high — regulatory]: The proposed merger with Acquiror 10VB8, LLC, valued at $83.50 per share, is pending antitrust approval from the European Commission. Failure to obtain this approval by February 13, 2026 (with a potential six-month extension) could lead to termination of the deal. Kellanova could owe a $1.25 billion termination fee if the merger fails due to regulatory approvals, while the Acquiror could owe an $800 million fee under certain circumstances.
• Impact of WK Kellogg Co Separation [medium — operational]: The separation of Kellanova's North America cereal business into WK Kellogg Co in Q4 2023 continues to affect operations. Transitional services under the TSA are concluding, and ongoing supply agreements are in place, which may introduce complexities and potential disruptions to business processes and financial reporting.
• Declining Profitability and Cash Position [high — financial]: Net income attributable to Kellanova decreased by 15.8% to $309 million in Q3 2025 from $367 million in Q3 2024. Diluted EPS fell to $0.88 from $1.05. Year-to-date net income also declined to $912 million from $978 million. Furthermore, cash and cash equivalents significantly decreased to $240 million as of September 27, 2025, from $694 million at December 28, 2024, indicating potential liquidity pressures.
• Increased Short-Term Debt [medium — financial]: Current maturities of long-term debt increased to $759 million from $632 million, and notes payable rose significantly to $526 million from $113 million. This increase in short-term obligations, coupled with a reduced cash position, warrants close monitoring of the company's short-term liquidity.

Industry Context

Kellanova operates in the global packaged food and beverage industry, facing intense competition from established multinational corporations and agile regional players. Key industry trends include a growing consumer demand for healthier, plant-based, and sustainably sourced products, alongside a shift towards convenience and digital engagement. The company's strategic decisions, such as the separation of its North America cereal business, reflect efforts to optimize its portfolio and focus on growth areas.

Regulatory Implications

The proposed merger with Acquiror 10VB8, LLC is subject to significant regulatory scrutiny, particularly from the European Commission regarding antitrust concerns. Failure to secure this approval could derail the transaction and result in substantial termination fees for Kellanova. Ongoing compliance with food safety regulations, labeling requirements, and international trade policies also remains critical.

What Investors Should Do

1. Monitor European Commission's antitrust review closely.
2. Analyze the impact of concluding TSA agreements.
3. Assess the company's liquidity and debt management.
4. Evaluate the sustainability of current revenue and profit trends.

Key Dates

• 2025-09-27: End of Q3 2025 reporting period — Reflects the latest financial performance data, showing a slight revenue increase but a notable decline in net income and EPS, alongside a significant drop in cash reserves.
• 2024-08-13: Entered into Merger Agreement with Acquiror 10VB8, LLC — Initiated the process for a potential acquisition at $83.50 per share, which is subject to regulatory approvals and carries significant termination fees.
• 2023-Q4: Separation of North America cereal business into WK Kellogg Co — This strategic separation continues to impact operational dynamics and financial reporting, with ongoing transitional services and supply agreements.
• 2026-02-13: Longstop date for merger completion — The deadline for the merger to be completed, with a potential extension, after which termination rights may be exercised, triggering substantial termination fees.

Glossary

Acquiror 10VB8, LLC

The entity that has entered into an agreement to acquire Kellanova. (Central to the proposed merger, the identity and intentions of the acquirer are critical for understanding the company's future.)

Merger Agreement

The legal contract outlining the terms and conditions for the proposed acquisition of Kellanova by Acquiror 10VB8, LLC. (Defines the transaction price, closing conditions (including regulatory approvals), and termination clauses and fees, impacting shareholder value and deal certainty.)

European Commission (EC)

The executive branch of the European Union, responsible for proposing legislation, implementing decisions, upholding EU treaties and managing the day-to-day business of the EU. In this context, it is responsible for antitrust review of the proposed merger. (Its antitrust approval is a critical condition for the completion of the proposed merger, posing a significant regulatory risk.)

Transitional Services Agreement (TSA)

An agreement where the seller of a business continues to provide certain services (e.g., IT, HR, finance) to the buyer for a specified period after the sale to ensure a smooth transition. (The conclusion of the TSA for the WK Kellogg Co separation indicates a shift towards independent operations for both entities, potentially introducing new operational challenges.)

Noncontrolling interests

The portion of equity in a subsidiary that is not attributable to the parent company. It represents the ownership interest of outside shareholders. (Fluctuations in noncontrolling interests can affect the net income attributable to Kellanova and the overall equity structure.)

Year-Over-Year Comparison

Compared to the prior year, Kellanova reported a slight increase in net sales for the quarter ($3,260M vs $3,233M), but experienced a significant 15.8% decline in net income attributable to Kellanova ($309M vs $367M) and a drop in diluted EPS ($0.88 vs $1.05). Year-to-date sales also saw a decrease ($9,546M vs $9,625M), with net income falling to $912M from $978M. A key change is the substantial reduction in cash and cash equivalents, down to $240M from $694M, signaling a weaker liquidity position. New risks related to the pending merger approval and the ongoing integration/separation impacts from WK Kellogg Co are now prominent.

Filing Documents

• k-20250927.htm (10-Q) — 2128KB
• k-2025q3ex311.htm (EX-31.1) — 9KB
• k-2025q3ex312.htm (EX-31.2) — 9KB
• k-2025q3ex321.htm (EX-32.1) — 4KB
• k-2025q3ex322.htm (EX-32.2) — 4KB
• k-20250927_g1.jpg (GRAPHIC) — 200KB
• 0000055067-25-000191.txt ( ) — 10404KB
• k-20250927.xsd (EX-101.SCH) — 47KB
• k-20250927_cal.xml (EX-101.CAL) — 107KB
• k-20250927_def.xml (EX-101.DEF) — 398KB
• k-20250927_lab.xml (EX-101.LAB) — 694KB
• k-20250927_pre.xml (EX-101.PRE) — 608KB
• k-20250927_htm.xml (XML) — 1655KB

— Financial Information

PART I — Financial Information Item 1: Condensed Consolidated Financial Statements Consolidated Balance Sheet — September 2 7 , 2025 and December 28, 2024 3 Consolidated Statement of Income — quarter and year-to-date periods ended September 2 7 , 2025 and September 2 8 , 2024 4 Consolidated Statement of Comprehensive Income – quarter and year-to-date periods ended September 2 7 , 2025 and September 2 8 , 2024 5 Consolidated Statement of Equity — quarter and year-to-date periods ended September 27, 2025 and September 28, 2024 6 Consolidated Statement of Cash Flows — year-to-date periods ended Septembe r 27, 2025 and September 28, 2024 8

Notes to Consolidated Financial Statements

Notes to Consolidated Financial Statements 9 Item 2:

Management's Discussion and Analysis of Financial Condition and Results of Operations 26

Management's Discussion and Analysis of Financial Condition and Results of Operations 26 Item 3:

Quantitative and Qualitative Disclosures about Market Risk 46

Quantitative and Qualitative Disclosures about Market Risk 46 Item 4:

Controls and Procedures 47

Controls and Procedures 47

— Other Information

PART II — Other Information Item 1A: Risk Factors 48 Item 2: Unregistered Sales of Equity Securities and Use of Proceeds 49 Item 6: Exhibits 50

Signatures

Signatures 49 Exhibit Index 51 Table of Contents

– FINANCIAL INFORMATION

Part I – FINANCIAL INFORMATION

FINANCIAL STATEMENTS

ITEM 1. FINANCIAL STATEMENTS. Kellanova and Subsidiaries CONSOLIDATED BALANCE SHEET (in millions of U.S. dollars, except per share data) (Unaudited) September 27, 2025 December 28, 2024 Current assets Cash and cash equivalents $ 240 $ 694 Accounts receivable, net 1,707 1,522 Inventories 1,199 1,165 Other current assets 319 373 Total current assets 3,465 3,754 Property, net 3,526 3,234 Operating lease right-of-use assets 578 601 Goodwill 5,056 5,003 Other intangibles, net 1,808 1,760 Investments in unconsolidated entities 112 99 Other assets 1,100 1,177 Total assets $ 15,645 $ 15,628 Current liabilities Current maturities of long-term debt $ 759 $ 632 Notes payable 526 113 Accounts payable 2,114 2,236 Current operating lease liabilities 150 134 Accrued advertising and promotion 626 611 Accrued salaries and wages 182 259 Other current liabilities 753 675 Total current liabilities 5,110 4,660 Long-term debt 4,341 4,998 Operating lease liabilities 424 465 Deferred income taxes 558 541 Pension liability 432 599 Other liabilities 485 483 Commitments and contingencies Equity Common stock, $ .25 par value 105 105 Capital in excess of par value 1,007 1,121 Retained earnings 9,696 9,358 Treasury stock, at cost ( 4,369 ) ( 4,533 ) Accumulated other comprehensive income (loss) ( 2,236 ) ( 2,276 ) Total Kellanova equity 4,203 3,775 Noncontrolling interests 92 107 Total equity 4,295 3,882 Total liabilities and equity $ 15,645 $ 15,628 See accompanying Notes to Consolidated Financial Statements. 3 Table of Contents Kellanova and Subsidiaries CONSOLIDATED STATEMENT OF INCOME (in millions of U.S. dollars, except per share data) (Unaudited) Quarter ended Year-to-date period ended September 27, 2025 September 28, 2024 September 27, 2025 September 28, 2024 Net sales $ 3,260 $ 3,233 $ 9,546 $ 9,625 Cost of goods sold 2,176 2,057 6,313 6,257 Selling, general and administrative expense 632 720 1,913 2,026 Operating profit 452

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS for the quarter ended September 27, 2025 (unaudited) NOTE 1 ACCOUNTING POLICIES Basis of presentation The unaudited interim financial information of Kellanova (the Company), included in this report reflects all adjustments, all of which are of a normal and recurring nature, that management believes are necessary for a fair statement of the results of operations, comprehensive income, financial position, equity and cash flows for the periods presented. This interim information should be read in conjunction with the financial statements and accompanying footnotes within the Company's 2024 Annual Report on Form 10-K as filed with the SEC on February 21, 2025. The balance sheet information at December 28, 2024 was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States. The results of operations for the quarter and year-to-date periods ended September 27, 2025 are not necessarily indicative of the results to be expected for other interim periods or the full year. Certain prior period amounts have been reclassified to conform with current period presentation. Proposed Merger On August 13, 2024, we entered into an Agreement and Plan of Merger (the "Merger Agreement") with Acquiror 10VB8, LLC, a Delaware limited liability company ("Acquiror"), Merger Sub 10VB8, LLC, a Delaware limited liability company and a wholly owned subsidiary of Acquiror ("Merger Sub"), and, solely for the limited purposes specified in the Merger Agreement, Mars, Incorporated, a Delaware corporation ("Mars"). The Merger Agreement provides that, subject to the terms and conditions set forth therein, at the effective time of the Merger (the "Effective Time"), (1) Merger Sub will be merged with and into the Company (the "Merger"), with the Company continuing as the surviving corporation and a wholly owned subsidiary of Acquiror, and (2) each share of pub

View Full Filing

View this 10-Q filing on SEC EDGAR